EUVIMEDObjevte EUVIMED
Übersichtsarbeit

Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney

Mohamed J Saadh, Hayaa M Alhuthali, Oblitas Gonzales Aníbal, José Ander Asenjo-Alarcón, Dhuha Ghassan Younus, Ahmed Alhili, Zainab Hussein Adhab, Ohud Alsalmi, Amal F Gharib, Renzon Daniel Cosme Pecho, Reza Akhavan-Sigari

Cell Biology International · 2024

DOI: 10.1002/cbin.12098 ↗

At a glance

Übersichtsarbeit in Cell Biology International, 2024. Written by Mohamed J Saadh and 10 co-authors. Institution: Faculty of Pharmacy, Middle East University, Amman, Jordan. Major MEDLINE topics: Extracellular Vesicles, Urologic Neoplasms, Mesenchymal Stem Cells. Cited 6 times so far (Crossref); 126 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Mesenchymal stem cells (MSCs) are recognized for their remarkable ability to differentiate into multiple cell types. They are also known to possess properties that can fight cancer, leading to attempts to modify MSCs for use in anticancer treatments. However, MSCs have also been found to participate in pathways that promote tumor growth. Many studies have been conducted to explore the potential of MSCs for clinical applications, but the results have been inconclusive, possibly due to the diverse nature of MSC populations. Furthermore, the conflicting roles of MSCs in inhibiting tumors and promoting tumor growth hinder their adaptation to anticancer therapies. Antitumorigenic and protumorigenic properties of MSCs in urological cancers such as bladder, prostate, and renal are not as well established, and data comparing them are still limited. MSCs hold significant promise as a vehicle for delivering anticancer agents and suicide genes to tumors. Presently, numerous studies have concentrated on the products derived from MSCs, such as extracellular vesicles (EVs), as a form of cell‐free therapy. This work aimed to review and discuss the current knowledge of MSCs and their EVs in urological cancer therapy.

Subjects

MeSH terms (MEDLINE)

Extracellular VesiclesUrologic NeoplasmsMesenchymal Stem CellsMaleHumansUrinary BladderProstateKidney

Author keywords

bladder cancerkidney cancermesenchymal stem cellsprostate cancerrenal pelvis cancer

Authors and institutions

  • Faculty of Pharmacy, Middle East University, Amman, Jordan.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Taif University, Taif, Saudi Arabia.
  • Universidad Nacional Autónoma de Chota, Chota, Cajamarca, Perú.
  • Department of Pharmacy, Al-Noor University College, Nineveh, Iraq.
  • Medical Technical College, Al-Farahidi University, Baghdad, Iraq.
  • Department of Pharmacy, Al-Zahrawi University College, Karbala, Iraq.

Cite

APA

Saadh, M. J., Alhuthali, H. M., Gonzales Aníbal, O., Asenjo-Alarcón, J. A., Younus, D. G., Alhili, A., Adhab, Z. H., Alsalmi, O., Gharib, A. F., Pecho, R. D. C., & Akhavan-Sigari, R. (2024). Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney. Cell Biology International. https://doi.org/10.1002/cbin.12098

Vancouver

Saadh MJ, Alhuthali HM, Gonzales Aníbal O, Asenjo-Alarcón JA, Younus DG, Alhili A, et al. Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney. Cell Biology International. 2024. doi:10.1002/cbin.12098

BibTeX
@article{Saadh2024,
  author = {Saadh, Mohamed J and Alhuthali, Hayaa M and Gonzales Aníbal, Oblitas and Asenjo-Alarcón, José Ander and Younus, Dhuha Ghassan and Alhili, Ahmed and Adhab, Zainab Hussein and Alsalmi, Ohud and Gharib, Amal F and Pecho, Renzon Daniel Cosme and Akhavan-Sigari, Reza},
  title = {Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney},
  journal = {Cell Biology International},
  year = {2024},
  doi = {10.1002/cbin.12098}
}
Start for free →